CURRENT MEDICAL AND DRUG RESEARCH

Articles>> Volume 5 Issue 1, 2021

CURRENT MEDICAL AND DRUG RESEARCH
The potential role of Bromhexine in the management of COVID-19: Decipher and a real game-changer
Hayder M. Al-Kuraishy, Marwa S. Al-Niemi, Nawar R. Hussain, Ali I. Al-Gareeb and Claire Lugnier
Curr Med Drug Res 5 (1): Art. ID 212 (2021)
Primary infection of SARS‐CoV‐2 (novel coronavirus or 2019‐nCoV), which leads to Covid-19, targets specific cells, such as nasal, bronchial epithelial and pneumocytes, through the viral structural spike (S) protein that binds to the angiotensin-converting enzyme 2 (ACE2) receptor. Also, type 2 transmembrane serine protease (TMPRSS2) present in the host cell promotes viral uptake by cleaving ACE2 and triggering the SARS-CoV-2 S protein, which facilitates SARS-CoV-2 entry into host cells. One of the TMPRSS2 inhibitors with a greater distribution capacity into the lung tissue is bromhexine hydrochloride which attenuates the entry and proliferation of SARS‐CoV‐2. Bromhexine is an effective drug in the management and treatment of Covid-19 pneumonia via targeting ACE2/ TMPRSS2 pathway. However, prospective and controlled clinical trials are recommended to confirm this observation.

Related Article

COVID-19 and risk of cardiomyocyte injury: The prevailing scenario
Marwa S. Al-Niemi, Nawar R. Hussain, Hayder M. Al-Kuraishy and Ali I. Al-Gareeb2
Curr Med Drug Res 5 (1): Art. ID 211 (2021)

Current and future role of immobilized enzymes in medical field
Mohammad Rafiq Khan
Curr Med Drug Res 5 (1): Art. ID 213 (2021)

Spatial mapping and enshrined capacity: Assessment of COVID-19 servicing Indian hospitals
N. Ravichandran, S. Shivangi and B. Rakesh
Curr Med Drug Res 5 (1): Art. ID 214 (2021)

Elucidation of the origin of autoimmune diseases via computational multiscale mechanobiology and extracellular matrix remodeling: theories and phenomenon of immunodominance
Rajiv Kumar
Curr Med Drug Res 5 (1): Art. ID 215 (2021)